JFrog stock rises as Cantor Fitzgerald maintains Overweight rating after strong Q2
Investing.com - Needham has downgraded Sapiens International Corp. NV (NASDAQ:SPNS) from Buy to Hold following the announcement of the company’s acquisition by Advent. According to InvestingPro data, Sapiens maintains a "GREAT" financial health score and has seen a significant 9.87% return over the past week.
Sapiens announced it has reached an agreement to be acquired by Advent for $43.50 per share in an all-cash transaction, valuing the company at an equity value of $2.5 billion. The deal represents a 64% premium over Sapiens’ closing price of $26.52 on August 8, 2025. The company, which has maintained dividend payments for 11 consecutive years, currently trades near its 52-week high.
The acquisition price reflects a price-to-earnings multiple of approximately 26.2x Needham’s FY26 estimate and roughly 22.2x EV/TTM EBITDA, compared to the undisturbed multiples of 15.1x P/E and 12.8x EV/TTM EBITDA.
Sapiens’ Board of Directors unanimously approved the transaction, which is expected to close by the fourth quarter of 2025 or first quarter of 2026. Needham cited the stock trading near the takeout price as the reason for the downgrade.
While reports about a potential transaction had appeared in media earlier this week, Needham expressed surprise at the "healthy premium" and views the deal as a favorable outcome for Sapiens shareholders. For deeper insights into Sapiens’ valuation metrics and financial performance, access the comprehensive Pro Research Report available on InvestingPro.
In other recent news, Sapiens International Corporation announced a significant development as it entered into a definitive agreement to be acquired by private equity firm Advent in an all-cash transaction valued at approximately $2.5 billion. This acquisition will see Sapiens shareholders receiving $43.50 per share in cash. Meanwhile, reports have surfaced that Sapiens’ parent company, Formula Systems, is in advanced talks to sell its controlling stake in the company, potentially valuing Sapiens at around $2 billion.
S&P Global reaffirmed Sapiens’ long-term issuer rating as "ilAA-" with a stable outlook, confirming the same rating for the company’s Series B Debentures. Additionally, Sapiens has released an AI-powered upgrade for its CoreSuite policy administration system, incorporating generative AI chatbots and predictive tools for life insurers. In another development, Rosenblatt Securities adjusted its outlook on Sapiens, lowering the stock target to $625 while maintaining a Buy rating. These recent developments highlight the dynamic changes surrounding Sapiens International Corporation.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.